BLOG

What is a CDMO and Why Does Your Company Need One?

What is a CDMO and Why Does…

What is a CDMO? A CDMO, also sometimes referred to…

Permeability Enhancers for Bioavailability Improvement

Permeability Enhancers for Bioavailability Improvement

A large number of promising compounds in the pharmaceutical pipelines…

Muco-Adhesion Testing

Muco-Adhesion Testing

Muco-Adhesion and Muco-adhesive Delivery Systems Muco-adhesion refers to the adhesion…

IVRT and IVPT: Pivotal Tools in Topical Product Development

IVRT and IVPT: Pivotal Tools in Topical…

Topical products are liquid or semi-solid dosage forms applied to…

Topical Dosage Forms: Product Development Overview

Topical Dosage Forms: Product Development Overview

Topical dosage forms are medications applied directly to the body…

Heterocyclic Compounds, the Backbone of Small Molecule Therapeutics

Heterocyclic Compounds, the Backbone of Small Molecule…

In the ever-evolving landscape of pharmaceuticals and drug discovery, researchers…

Pharmaceutical Suspensions – Part 2: Formulation Development

Pharmaceutical Suspensions – Part 2: Formulation Development

Early Preformulation Studies For the development of a robust suspension…

Pharmaceutical Suspension Formulations – Part 1: An Overview of Key Advantages and Desirable Properties

Pharmaceutical Suspension Formulations – Part 1: An…

What are Pharmaceutical Suspensions Liquid oral dosage forms such as…

Buccal Delivery Systems (Part 3) – Improving Bioavailability through Buccal Route

Buccal Delivery Systems (Part 3) – Improving…

Poor bioavailability is a common problem for a majority of…

Buccal Delivery Systems | Part 2: Applications and Dosage Forms

Buccal Delivery Systems | Part 2: Applications…

Why Buccal Delivery  Buccal cavity in the mouth is an…

Buccal Delivery Systems | Part 1: Opportunities and Challenges

Buccal Delivery Systems | Part 1: Opportunities…

The buccal region is the mouth cavity offers unique benefits…

The science of pharmaceutical taste masking

The science of pharmaceutical taste masking

Taste masking is often used in the pharmaceutical industry to…

Will the US FDA accept foreign clinical trials?

Will the US FDA accept foreign clinical…

In the past, the FDA only accepted clinical studies that…

FDA approval pathways: the 505b2

FDA approval pathways: the 505b2

Pharmaceutical innovation stems from a variety of sources. Practicing doctors…

Vici can now export and import DEA schedule 1-5 controlled substances to support clinical development

Vici can now export and import DEA…

Vici Health Sciences, a customer-focused pharmaceutical CDMO that offers formulation…

Nitrosamine risk evaluation and testing, what’s next?

Nitrosamine risk evaluation and testing, what’s next?

Nitrosamine compounds have long been considered probable human carcinogens. Nitrosamines…

Creating Formulation Intellectual Property during Drug Development – FAQ

Creating Formulation Intellectual Property during Drug Development…

Why must companies consider formulation patents? Pharmaceutical drug development is…

CMO versus CDMO: what’s the difference and how this decision is make or break for early phase drug development programs

CMO versus CDMO: what’s the difference and…

Choosing the right organization to develop drugs is the single…

Focusing on medicine for patients with swallowing difficulties

Focusing on medicine for patients with swallowing…

Vici Health Sciences, a Maryland-based CDMO is pleased to introduce…

Vici now offers cGMP API and intermediates synthesis services to support phase 1 clinical and GLP nonclinical studies

Vici now offers cGMP API and intermediates…

Vici Health Sciences, a Maryland-based CDMO is pleased to introduce…